Dispensing channel and medication adherence: Evidence across 3 therapy classes

American Journal of Managed Care

Volumn 19, Issue 10, 2013, Pages 798-804

  Iyengar, Reethi ^a   Henderson, Rochelle ^a   Visaria, Jay ^a   Frazee, Sharon Glave ^a  

^a Research and New Solutions Express Scripts   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL PHARMACY; DIABETES MELLITUS; DRUG USE; EVIDENCE BASED PRACTICE; FOLLOW UP; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MEDICATION COMPLIANCE; PATIENT COMPLIANCE; PRIORITY JOURNAL; ADOLESCENT; CHRONIC DISEASE; INSURANCE; MIDDLE AGED; PHARMACY; POSTAL MAIL; RETROSPECTIVE STUDY; STATISTICAL MODEL; YOUNG ADULT;

ADOLESCENT; ADULT; CHRONIC DISEASE; HUMANS; INSURANCE CLAIM REVIEW; LOGISTIC MODELS; MEDICATION ADHERENCE; MIDDLE AGED; PHARMACEUTICAL SERVICES; PHARMACIES; POSTAL SERVICE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84887219753     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487-497.
2. Brunton SA. Improving medication adherence in chronic disease management. J Fam Pract. 2011;60(4)(suppl improving):S1-S8.
3. Albert NM. Improving medication adherence in chronic cardiovascular disease. Crit Care Nurse. 2008;28(5):54-64.
4. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and health care cost. Med Care. 2005;43(6):521-530.
5. Stuart BC, Simoni-Wastila L, Zhao L, Lloyd JT, Doshi JA. Increased persistency in medication use by U.S. Medicare beneficiaries with diabetes is associated with lower hospitalization rates and cost savings. Diabetes Care. 2009;32(4):647-649.
6. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002; 40(9):794-811.
7. McDermott MM, Schmitt B, Wallner E. Impact of medication nonadherence on coronary heart disease outcomes: a critical review. Arch Intern Med. 1997;157(17):1921-1929.
8. Nasseh K, Frazee SG, Visaria J, Vlahiotis A, Tian Y. Cost of medication nonadherence associated with diabetes, hypertension, and dyslipidemia. Am J Pharm Benefits. 2012;4(2):e41-e47.
9. Zhang L, Zakharyan A, Stockl KM, Harada AS, Curtis BS, Solow BK. Mail-order pharmacy use and medication adherence among Medicare Part D beneficiaries with diabetes. J Med Econ. 2011;14(5):562-567.
10. Duru OK, Schmittdiel JA, Dyer WT, et al. Mail-order pharmacy use and adherence to diabetes-related medications. Am J Manag Care. 2010;16(1):33-40.
11. Sharma KP, Taylor TN. Pharmacy effect on adherence to antidiabetic medications. Med Care. 2012;50(8):685-691.
12. Carroll NV, Brusilovsky I, York B, Oscar R. Comparison of costs of community and mail service pharmacy. J Am Pharm Assoc (2003). 2005;45(3):336-343.
13. Visaria J, Frazee SG, Devine ST. Asthma controller adherence in mail order pharmacy compared to retail pharmacy. Am J Pharm Benefits. 2012;4(3):e73-e80.
14. Khandelwal N, Duncan I, Rubinstein E, et al. Medication adherence for 90-day quantities of medication dispensed through retail and mail order pharmacies. Am J Manag Care. 2011;17(11):e427-e434.
15. Liberman JN, Girdish C. Recent trends in the dispensing of 90-daysupply prescriptions at retail pharmacies: implications for improved convenience and access. Am Health Drug Benefits. 2011;4(2):95-100.
16. Brennan TA, Dollear TJ, Hu M, et al. An integrated pharmacy-based program improved medication prescription and adherence rates in diabetes patients. Health Aff (Millwood). 2012;31(1):120-129.
17. Samaras K, Campbell LV, Chisholm DJ. Can the effectiveness of physical activity programs be improved? response to Clark. Diabetes Care. 1998;21(1):195-196.
18. Giannetti V. Adherence to therapeutic regimens. Res Social Adm Pharm. 2005;1(3):375-377.
19. Shay LE. A concept analysis: adherence and weight loss. Nurs Forum. 2008;43(1):42-52.
20. Krumholz HM. Outcomes research: generating evidence for best practice and policies. Circulation. 2008;118(3):309-318.
21. Brookhart MA, Stürmer T, Glynn RJ, Rassen J, Schneeweiss S. Confounding control in healthcare database research: challenges and potential approaches. Med Care. 2010;48(6) suppl):S114-S120.
22. Patrick AR, Shrank WH, Glynn RJ, et al. The association between statin use and outcomes potentially attributable to an unhealthy lifestyle in older adults. Value Health. 2011;14(4):513-520.
23. Pittman DG, Chen W, Bowlin S, Foody JM. Adherence to statins, subsequent healthcare costs, and cardiovascular hospitalizations. Am J Cardiol. 2011;107(11):1662-1666.
24. Janis IB, Nock MK. Behavioral forecasts do not improve the prediction of future behavior: a prospective study of self-Injury. J Clin Psychol. 2008;64(10):1-11.
25. Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC. An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients. Med Care. 2008;46(11):1125-1133.
26. Devine S, Vlahiotis A, Sundar H. A comparison of diabetes medication adherence and healthcare costs in patients using mail order pharmacy and retail pharmacy. J Med Econ. 2010;13(2):203-211.
27. US Census Bureau. Metropolitan and micropolitan statistical areas main. http://www.census.gov/population/metro/. Revised May 24, 2012. Accessed August 21, 2012.
28. Brookhart MA, Patrick AR, Dormuth C, et al. Adherence to lipidlowering therapy and the use of preventive health services: an investigation of the healthy user effect. Am J Epidemiol. 2007;166(3):348-354.
29. Fryar CD, Hirsch R, Eberhardt MS, Yoon SS, Wright JD. Hypertension, high serum total cholesterol, and diabetes: racial and ethnic prevalence differences in U.S. adults, 1999-2006. NCHS Data Brief. 2010;(36):1-8.